The use of finasteride for treating male pattern baldness has come under scrutiny due to emerging concerns about its potential mental health side effects. While the medication has effectively helped many men combat hair loss, discussions are intensifying around its possible links to depression, anxiety, and suicidal thoughts. This has prompted both users and healthcare professionals to reevaluate its safety profile.
Understanding Finasteride’s Mechanism
Finasteride is primarily prescribed for androgenetic alopecia, commonly known as male pattern baldness. The drug operates by inhibiting the conversion of testosterone into dihydrotestosterone (DHT), a hormone that contributes significantly to hair follicle miniaturization. When DHT binds to hair follicles, it shortens the hair growth cycle, leading to thinner and weaker hair.
Approved in the late 1990s, finasteride is typically administered as a 1 milligram oral tablet taken daily. A higher dosage of 5 milligrams is available but is primarily used for treating non-cancerous prostate enlargement. It is important to note that finasteride is not recommended for women, though they also experience similar types of hair loss.
Mental Health Concerns Associated with Finasteride
While the Australian guidelines for healthcare professionals do not list changes in mental health as a known side effect, clinical trials have indicated that the most common adverse effects include sexual dysfunction and a potential increased risk of prostate and breast cancer, the latter being relevant to men as well. Initial trials did not reveal any mental health issues; however, ongoing monitoring has raised alarms.
In May 2025, the European Medicines Agency safety committee confirmed suicidal thoughts as a side effect of finasteride. The agency has since advised that the drug may lead to a depressed mood and depression. Similarly, the United States Food and Drug Administration issued a warning in April 2025 regarding compounded formulations of finasteride, stating that they carry similar mental health risks as the oral version.
Patients experiencing mood changes while on finasteride are advised to consult with their healthcare providers. Those noticing significant emotional shifts should not try to manage these changes alone. Doctors may suggest pausing the medication to assess whether symptoms improve or, in more severe cases, discontinuing the drug and seeking immediate medical attention.
If a patient chooses to stop taking finasteride, they can do so safely. Most side effects tend to dissipate once the medication is cleared from the body. However, a subset of users has reported persistent symptoms. It is crucial to understand that discontinuing finasteride will result in a gradual return to baseline hormone levels, meaning any hair regrowth achieved while on the drug will eventually be lost.
For those who find finasteride unsuitable, alternatives are available. Topical minoxidil is a first-line treatment that can be used independently or in conjunction with other therapies. Though it may cause scalp irritation, its effectiveness is well-documented. The incidence of depression and anxiety linked to minoxidil is significantly lower than with oral finasteride due to its topical application.
Another potential alternative is dutasteride, which functions similarly to finasteride. However, its mental health implications warrant caution, making it advisable to avoid this option if finasteride is not suitable.
As discussions about the side effects of finasteride continue, it is essential for patients to remain informed. Nial Wheate, Professor at the School of Natural Sciences, Macquarie University, and Jasmine Lee, a Pharmacist and PhD Candidate at the University of Sydney, emphasize the importance of understanding both the benefits and risks associated with this common treatment.
For those affected by these issues or who require support, it is recommended to seek help from mental health professionals or consult crisis hotlines available in their respective countries.
